Biotech breakthroughs on the horizon in 2023

Several powerful headwinds - including surging inflation, rising interest rates, and the outbreak of war in Europe - contributed to heightened volatility across global markets in 2022, and the biotech space was not immune. While uncertainty and turbulence will likely persist this year, as global markets adapt to a new regime of elevated rates and slowing growth, the coming months offer cause for optimism around biotech. UK retail sales unexpectedly rise in January Abounding scientific innovation continues to fuel the supply of new drugs for the sector, and 2022 bore witness to a re...